Apotex Eyes Generic Version Of Cephalon's Nuvigil

Law360, New York (July 12, 2010, 6:49 PM EDT) -- Apotex Corp. is the latest to set its sights on making a generic version of Cephalon Inc.'s narcolepsy and sleep apnea drug Nuvigil, alerting Cephalon that it is seeking regulatory approval for a new version of the drug and has challenged the validity of three patents.

In filings with the U.S. Securities and Exchange commission Wednesday, Cephalon said it was considering its options but had not ruled out launching a patent infringement suit against Apotex that would at least delay any new drug's entrance into the...
To view the full article, register now.